Minimally Displaced Femoral Neck Fracture Pilot Study

NCT05947058 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-02-13

No results posted yet for this study

Summary

The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy minimally displaced femoral neck fracture (FNF) treated with surgery will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, hip arthroplasty or internal fixation. Participants will be followed for 1 year.

Conditions

  • Femoral Neck Fractures

Interventions

PROCEDURE

Arthroplasty

The type of hip prothesis (hemi or total; cemented or uncemented) will be at the discretion of the treating surgeon.

PROCEDURE

Internal Fixation

Both fixed angle devices and multiple screws will be permitted for the internal fixation group.

Sponsors & Collaborators

  • Orthopaedic Trauma Association

    collaborator OTHER
  • McMaster University

    collaborator OTHER
  • University of Southern California

    collaborator OTHER
  • University of California, Irvine

    collaborator OTHER
  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Gerard Slobogean, MD · University of Maryland, Baltimore

  • Sheila Sprague, PhD · McMaster University

  • Joseph Patterson, MD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Canada
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947058 on ClinicalTrials.gov